DSCSA: FDA gives firms more leeway on verification requests
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsSupply Chain ManagementRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsSupply Chain Management